Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma
Authors:
- 5 July 2007
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 134 (1) , 83-91
Abstract
It has been indicated that activated hepatic stellate cells (HSCs) play key roles on the pathogenesis of hepatocellular carcinoma (HCC). The purpose of the study was to investigate the potential mechanism in it.Keywords
This publication has 44 references indexed in Scilit:
- Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF‐β dependent fashionJournal of Cellular Physiology, 2006
- Fibroblasts in cancerNature Reviews Cancer, 2006
- Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancerNature Reviews Cancer, 2006
- Chromatin modifier enzymes, the histone code and cancerEuropean Journal of Cancer, 2005
- Menin represses JunD transcriptional activity in protein kinase Cθ-mediated Nur77 expressionExperimental & Molecular Medicine, 2005
- Involvement of histone hypoacetylation in Ni2+-induced bcl-2 down-regulation and human hepatoma cell apoptosisJBIC Journal of Biological Inorganic Chemistry, 2004
- Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factorNature Medicine, 2002
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Hepatic stellate cell activation in dysplastic nodules: evidence for an alternate hypothesis concerning human hepatocarcinogenesisLiver International, 1997
- Evidence that “myofibroblast-like” cells are the cellular source of capsular collage in hepatocellular carcinomaJournal of Hepatology, 1997